Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edward George Meloni, Ph.D.

Co-Author

This page shows the publications co-authored by Edward Meloni and William Carlezon.
Connection Strength

4.274
  1. Meloni EG, Kaye KT, Venkataraman A, Carlezon WA. PACAP increases Arc/Arg 3.1 expression within the extended amygdala after fear conditioning in rats. Neurobiol Learn Mem. 2019 01; 157:24-34.
    View in: PubMed
    Score: 0.871
  2. Meloni EG, Venkataraman A, Donahue RJ, Carlezon WA. Bi-directional effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on fear-related behavior and c-Fos expression after fear conditioning in rats. Psychoneuroendocrinology. 2016 Feb; 64:12-21.
    View in: PubMed
    Score: 0.706
  3. Meloni EG, Reedy CL, Cohen BM, Carlezon WA. Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol Psychiatry. 2008 May 01; 63(9):832-9.
    View in: PubMed
    Score: 0.407
  4. Meloni EG, Jackson A, Gerety LP, Cohen BM, Carlezon WA. Role of the bed nucleus of the stria terminalis (BST) in the expression of conditioned fear. Ann N Y Acad Sci. 2006 Jul; 1071:538-41.
    View in: PubMed
    Score: 0.369
  5. Meloni EG, Gerety LP, Knoll AT, Cohen BM, Carlezon WA. Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci. 2006 Apr 05; 26(14):3855-63.
    View in: PubMed
    Score: 0.363
  6. Meloni EG, Jackson AV, Cohen BM, Carlezon WA. Corticotropin-releasing factor from the rat brain measured by protein immunoblot. Peptides. 2005 Nov; 26(11):2252-6.
    View in: PubMed
    Score: 0.344
  7. Robble MA, Holloway IL, Ridener E, Webber CJ, Caine SB, Meloni EG, Desai RI, Carlezon WA. Differential Effects of Nicotine and Nicotine Withdrawal on Fear Conditioning in Male Rats. Int J Neuropsychopharmacol. 2020 Jul 29; 23(7):469-479.
    View in: PubMed
    Score: 0.245
  8. Donahue RJ, Venkataraman A, Carroll FI, Meloni EG, Carlezon WA. Pituitary Adenylate Cyclase-Activating Polypeptide Disrupts Motivation, Social Interaction, and Attention in Male Sprague Dawley Rats. Biol Psychiatry. 2016 12 15; 80(12):955-964.
    View in: PubMed
    Score: 0.172
  9. Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG, Carroll FI, Nestler EJ, Konradi C, Carlezon WA. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry. 2011 Sep 01; 70(5):425-33.
    View in: PubMed
    Score: 0.129
  10. Muschamp JW, Van't Veer A, Parsegian A, Gallo MS, Chen M, Neve RL, Meloni EG, Carlezon WA. Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats. J Neurosci. 2011 Feb 23; 31(8):3095-103.
    View in: PubMed
    Score: 0.127
  11. Cunningham MG, Connor CM, Carlezon WA, Meloni E. Amygdalar GABAergic-rich neural grafts attenuate anxiety-like behavior in rats. Behav Brain Res. 2009 Dec 14; 205(1):146-53.
    View in: PubMed
    Score: 0.113
  12. Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther. 2007 Dec; 323(3):838-45.
    View in: PubMed
    Score: 0.100
  13. Carlezon WA, Rohan ML, Mague SD, Meloni EG, Parsegian A, Cayetano K, Tomasiewicz HC, Rouse ED, Cohen BM, Renshaw PF. Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol Psychiatry. 2005 Mar 15; 57(6):571-6.
    View in: PubMed
    Score: 0.084
  14. Li Y, Meloni EG, Carlezon WA, Milad MR, Pitman RK, Nader K, Bolshakov VY. Learning and reconsolidation implicate different synaptic mechanisms. Proc Natl Acad Sci U S A. 2013 Mar 19; 110(12):4798-803.
    View in: PubMed
    Score: 0.037
  15. Cho JH, Zushida K, Shumyatsky GP, Carlezon WA, Meloni EG, Bolshakov VY. Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit. J Neurosci. 2012 Oct 10; 32(41):14165-77.
    View in: PubMed
    Score: 0.036
  16. Cho JH, Bayazitov IT, Meloni EG, Myers KM, Carlezon WA, Zakharenko SS, Bolshakov VY. Coactivation of thalamic and cortical pathways induces input timing-dependent plasticity in amygdala. Nat Neurosci. 2011 Dec 11; 15(1):113-22.
    View in: PubMed
    Score: 0.034
  17. Wong DL, Tai TC, Wong-Faull DC, Claycomb R, Meloni EG, Myers KM, Carlezon WA, Kvetnansky R. Epinephrine: a short- and long-term regulator of stress and development of illness : a potential new role for epinephrine in stress. Cell Mol Neurobiol. 2012 Jul; 32(5):737-48.
    View in: PubMed
    Score: 0.033
  18. Smith KS, Meloni EG, Myers KM, Van't Veer A, Carlezon WA, Rudolph U. Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice. Psychopharmacology (Berl). 2011 Feb; 213(4):697-706.
    View in: PubMed
    Score: 0.031
  19. Riccio A, Li Y, Moon J, Kim KS, Smith KS, Rudolph U, Gapon S, Yao GL, Tsvetkov E, Rodig SJ, Van't Veer A, Meloni EG, Carlezon WA, Bolshakov VY, Clapham DE. Essential role for TRPC5 in amygdala function and fear-related behavior. Cell. 2009 May 15; 137(4):761-72.
    View in: PubMed
    Score: 0.028
  20. Youngs RM, Chu MS, Meloni EG, Naydenov A, Carlezon WA, Konradi C. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J Neurosci. 2006 May 31; 26(22):6031-9.
    View in: PubMed
    Score: 0.023
  21. Goussakov I, Chartoff EH, Tsvetkov E, Gerety LP, Meloni EG, Carlezon WA, Bolshakov VY. LTP in the lateral amygdala during cocaine withdrawal. Eur J Neurosci. 2006 Jan; 23(1):239-50.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.